NASDAQ

Coinbase, the leading United States cryptocurrency exchange, has finally launched on NASDAQ, with a 50 percent increase in the share price. Coinbase Valuation Has Surpassed $100 Billion The Coinbase Shares (ticker symbol COIN) began trading on the stock exchange on Wednesday at the market price of $381 USD. This is…

According to a statement from its issuer, the first North American Bitcoin ETF has already reached $1 billion (C$1.25 billion) in assets less than two months after its launch. What exchange-traded funds did to the conventional investing market for decades could happen to cryptocurrency players in a fraction of the…

TUCSON, April 14, 2021 /PRNewswire/ -- (NASDAQ: RDFN) -- RedfinNow has expanded to the Tucson metro area and reopened in Las Vegas after temporarily pausing operations there due to the pandemic. RedfinNow is the iBuying service from Redfin (www.redfin.com), the technology-powered real estate brokerage, which gives homeowners a convenient new way…

Image credit: Michael Saylor The NASDAQ-listed business intelligence company, MicroStrategy, has revealed in a recent filing with the United States Securities and Exchange Commission (SEC) that some of its Board of Directors will receive their compensations in Bitcoin (BTC). MicroStrategy to Pay in BTC for Board Services In the Form…

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today positive interim results from the ongoing Phase 1 study of ALN-AGT, a subcutaneous investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) for the treatment of hypertension. Results were presented during a late-breaking oral presentation at the 2021 Joint Meeting…

On April 9, 2021, the Delaware-based company and sponsor of the “Kryptoin Bitcoin ETF Trust” filed an S1 amendment for a bitcoin exchange-traded fund (ETF) with the U.S. Securities and Exchange Commission (SEC). The asset manager re-filed its 2019 ETF application and instead of leveraging NYSE, the company plans to…

GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that a Phase 1b trial of GMI-1359, being conducted at Duke University Cancer Center, showed evidence of on-target effects, immune-activation and cell mobilization in the initial two patients treated with the Company's dual antagonist of E-selectin and CXCR4. Dorothy Sipkins, MD, PhD, Associate Research…

GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that an abstract presenting the results of a recent preclinical study on the therapeutic effects of GMI-1757, a new glycomimetic with dual antagonism to E-selectin and galectin-3, has been accepted for a... GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that an abstract presenting the results…

Author of the article: BRUKINSA is now commercially available in Canada following approval in March.Canadian patients now have access to the myBeiGene® patient support program. MISSISSAUGA, Ontario — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the official…

NEC and Cisco expand strategic partnership to help advance global deployments of 5G IP transport networks TOKYO, Apr 08, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701), a leader in the integration of IT and network technologies, and Cisco (NASDAQ: CSCO) today announced they have entered a Global System…